KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BNP PARIBAS FINANCIAL MARKETS | 3,690 | $35,535 | 0.00% |
FMR LLC | 57,566 | $554,360 | 0.00% |
BANK OF AMERICA CORP /DE/ | 22,461 | $216,300 | 0.00% |
WELLS FARGO & COMPANY/MN | 7,431 | $71,560 | 0.00% |
AMERICAN CENTURY COMPANIES INC | 22,153 | $213,333 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 10,627 | $102,338 | 0.00% |
GROUP ONE TRADING, L.P. | 13,955 | $134,387 | 0.00% |
Legal & General Group Plc | 1,952 | $18,798 | 0.00% |
BALYASNY ASSET MANAGEMENT L.P. | 10,670 | $102,752 | 0.00% |
STATE STREET CORP | 459,346 | $4,423,502 | 0.00% |
NATIXIS | 5,000 | $48,150 | 0.00% |
PRICE T ROWE ASSOCIATES INC /MD/ | 18,961 | $183 | 0.00% |
NEW YORK STATE COMMON RETIREMENT FUND | 9,959 | $96 | 0.00% |
NISA INVESTMENT ADVISORS, LLC | 4,339 | $41,785 | 0.00% |
STRS OHIO | 10,800 | $104 | 0.00% |
DEUTSCHE BANK AG\ | 11,879 | $114,395 | 0.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 65,154 | $627,433 | 0.00% |
GOLDMAN SACHS GROUP INC | 208,812 | $2,010,860 | 0.00% |
MORGAN STANLEY | 209,928 | $2,021,607 | 0.00% |
External links
This page lists KALVISTA PHARMACEUTICALS INC's shareholders in Q3 2023. To view KALVISTA PHARMACEUTICALS INC's shareholder history, click here.